electroCore to Present at 34th Annual Roth Conference
07 mars 2022 16h01 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results on Thursday, March 10
03 mars 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 03, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the...
U.S. Post-acute Care Market revenue worth USD 578 Billion by 2028, Says Global Market Insights Inc.
01 mars 2022 07h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, March 01, 2022 (GLOBE NEWSWIRE) -- U.S. post-acute care market value is poised to surpass USD 578 billion by 2028, according to a new research report by Global Market...
Worldwide Neurorehabilitation Industry to 2030 - Rising Demand of Telerehabilitation Presents Opportunities
17 févr. 2022 05h43 HE
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Neurorehabilitation Market by Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke
09 févr. 2022 08h00 HE
|
electroCore, Inc.
Clinical Trial (n=69) suggests safety and feasibility of nVNS for the acute treatment of stroke. Relative Ischemic Lesion Growth Decreased by 65.9% with nVNS vs. Sham Treatment. ROCKAWAY, N.J.,...
electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus
01 févr. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 01, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced enrollment has been completed for the TRANSIT...
electroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022
25 janv. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 25, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced three abstracts focusing on the possible...
Dr. David Margulies and Dr. Hal C. Lewis Present HEALING and REGENERATING the INJURED BRAIN
19 janv. 2022 14h00 HE
|
The Dan Lewis Foundation for Brain Regeneration Research
DENVER, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Talks at Google, a global talk series, recently presented Healing and Regenerating the Injured Brain with Dr. Hal Lewis and Dr. David Margulies. Drs. Lewis...
gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
12 janv. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that its gammaCore™ nVNS device has received...
electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store
11 janv. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce shop for patients...